Global Shingles Vaccine Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Shingles Vaccine Market was valued at $5.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 13.5% CAGR, to an estimated market size of $10.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The market encompasses the development, distribution, and administration of vaccines designed to prevent herpes zoster (shingles) and its complications, such as postherpetic neuralgia, primarily targeting the aging adult population and immunocompromised individuals.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Shingles Vaccine Market in the period 2025-30:
- The aging global population is the primary driver, as the risk of shingles and its complications increases significantly for individuals over the age of 50.
- There is a decisive market shift toward recombinant subunit vaccines like Shingrix due to their superior efficacy and safety profile compared to older live-attenuated versions.
- The inclusion of shingles vaccines in national immunization programs across developed and emerging economies is significantly lowering barriers to access and increasing uptake.
- Growing clinical interest in mRNA-based platforms aims to improve vaccine thermostability and simplify dosing schedules to enhance patient adherence.
- Increased public health focus on preventing postherpetic neuralgia (PHN) is driving proactive vaccination as a cost-saving measure for healthcare systems.
- Expansion into emerging markets in the Asia-Pacific region is being fueled by rising healthcare expenditures and regulatory approvals for local vaccine candidates.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia Pacific
- Rest of World
Segments
- Recombinant Subunit Vaccines
- Live Attenuated Vaccines
- mRNA & Other Technologies